On Demand Pharmacology CME

Recorded Live at ULS Conferences

Recorded On Title Speaker Hours Price Learning Objectives (summary)
2025-09-18 Pharmacogenomics and Updates in Diabetes Management Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM 5 $125
  • Apply pharmacogenomics to individualized therapy decisions.
  • Assess key CYP450/drug–drug interaction considerations.
  • Use updated diabetes guidance (CV/renal) + CGM to optimize regimens.
  • Apply updates via interactive patient cases.
2025-09-17 Women’s Health and Preventative Medicine Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM 5 $125
  • Pregnancy/lactation guideline considerations.
  • Contraception & emergency contraception updates.
  • Menopause HRT guidance; osteoporosis prevention options.
  • RSV and pneumococcal vaccination updates.
2025-09-16 Honing in on Herbal Remedies, Overcoming Obesity, and Drug Therapy Jeopardy Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS 5 $125
  • Herbals: evidence, risks/interactions, evaluation framework.
  • Obesity: who benefits, compare options/AEs, emerging therapies.
  • Drug therapy review: monitoring/labs + practical pearls.
2025-08-28 New Hypertension Guidelines Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP 1 $25
  • First-line treatment updates and preferences.
  • When/how to use combination therapy.
  • Guideline-based management of resistant HTN.
2025-08-28 Drug induced Nutrient Depletions Dr. Sandford Levy, M.D. 1 $25
  • How medications can affect nutritional status and depletion risk.
2025-08-28 Drug and Alcohol Withdrawal Treatment from ER Through Discharge Dr. Randell L. Tackett, Ph.D 1 $25
  • Withdrawal management from ED evaluation through discharge planning.
2025-08-28 Cannabis and Cannabinoid-Based Therapies Dr. Randell L. Tackett, Ph.D 1 $25
  • Clinical applications and regulatory considerations.
  • Pharmacokinetics and key interactions.
2025-08-28 Pharmacogenomics in Primary Care Therapy Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM 1 $25
  • Personalize medication selection using genetic profiles.
  • Recognize key CYP450 interactions.
  • Interpret PGx testing and apply results.
2025-08-28 Hormone Replacement Therapy Update Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM 1 $25
  • Updated menopause HRT guidance.
  • Risks/benefits of newer formulations and delivery methods.
2025-08-29 Psychopharmacology Trends Dr. Joshua Caballero, Pharm.D., BCPP, FCCP 1 $25
  • Updates on newer antidepressants/antipsychotics (incl. off-label use).
  • Recognize/manage polypharmacy in mental health care.
  • Practical use in primary care.
2025-08-27 Immunotherapy and Biologics in Autoimmune Disease Dr. Kajal Jain, Pharm.D 4 $95
  • Monoclonal antibodies used in common autoimmune diseases.
  • Safety monitoring essentials for biologics.
  • Key patient education points.
2025-08-27 Dental Prophylaxis Dr. Anna Paritsky DMD, DDS 4 $95
  • AHA/ADA dental prophylaxis recommendations.
  • Which patients/procedures require prophylaxis.
  • Recommended antibiotics and dosing.
2025-08-27 Antimicrobial Stewardship Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS 2 $50
  • Outpatient antimicrobial prescribing best practices.
  • New agents and notable indications.
  • Penicillin allergy assessment and de-labeling.
2025-08-27 Pain Management Dr. Stacey Hollen PharmD, BCACP 4 $95
  • Apply 2022 CDC opioid guideline concepts to practice.
  • Communicate benefits/risks; evaluate alternatives.
  • Identify overdose risks; mitigate + screen.
  • Consider non-opioids and buprenorphine options.
2025-06-11 Reframing Our Approach to Personalize the Management of Type 2 Diabetes Cory Jenks PharmD, BCPS, BCACP 5 $125
  • Understand insulin resistance physiology in T2D.
  • Relate insulin to medication mechanisms.
  • Review evidence for carbohydrate restriction.
  • Personalize care using EBM tools.
2025-06-10 Pharmacological Strategies to Manage Symptoms of Palliative Care Patients Dr. Gregory L. Holmquist, PharmD, CPE 5 $125
  • Medication goals in palliative care; symptom patterns.
  • Opioids + adjuvants; best practices.
  • Strategies for nausea, dyspnea, anxiety, constipation, insomnia, etc.
  • Deprescribing/optimization principles.
2025-04-24 New Drug Update Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP 10 $200
  • FDA communications: labeling changes, warnings, new indications, alerts.
  • New drugs: pharmacology/PK, indications, AEs, interactions.
  • Compare efficacy/dose/cost and evidence strength.
  • Cost/benefit vs existing and lower-cost agents.
2025-02-20 Major Depression, Anxiety and Sleep Disorders, Off Label Prescribing of Mood Stabilizers Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA 3 $75
  • Depression: guideline-based choices and management.
  • Anxiety/sleep: recognition + evidence-based therapies.
  • Off-label mood stabilizers for agitation/insomnia/behavioral symptoms.
2025-02-19 Osteoporosis and Chronic Kidney Disease Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA 2 $50
  • Assess fracture risk and secondary causes in CKD.
  • Compare osteoporosis meds with renal dosing/contraindications.
  • Monitoring and safety considerations.
2025-02-18 Best Practices in Prescribing Opioid Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA 3 $75
  • Guideline-aligned opioid prescribing best practices.
  • Risk assessment, monitoring, mitigation strategies.
  • Alternatives, tapering, safer workflows.
2024-12-12 Current Practice Update: Opioids, Cannabinoids and Gabapentenoids for Managing Pain Dr. Gregory L. Holmquist, PharmD, CPE 5 $125
  • Core pain concepts/risks; assess misuse risk factors.
  • Compare opioids vs cannabinoids vs gabapentenoids.
  • Monitoring models; formulation comparisons; counseling.
2024-10-09 Drug Update 2024 (Part 1 and Part 2) Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP 3 $75
  • Identify 10–20 new medications.
  • Discuss use, side effects, interactions, and benefits.
  • Review major labeling/indication updates.
2024-08-28 An Evidence-Based Approach to Treating T2D in Adults Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP 2 $50
  • Apply 2024 ADA Standards of Care.
  • Use trial outcomes supporting complication risk reduction.
  • Outcomes-based risk reduction (CVD/HF/CKD/obesity).
2024-08-29 Treatment of Anaphylaxis in Primary care and Acute care and Seizures in Acute care Dr. Andrea Sikora Pharm.D., MSCR, FCCM, BCCCP 1 $25
  • Evidence-based approach to anaphylaxis.
  • Create an acute seizure management plan.
  • Identify common AED adverse effects.
2024-08-29 Pharmacotherapy of Chronic Kidney Disease Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS 2 $50
  • SGLT2/GLP-1/finerenone roles in CKD progression prevention.
  • Hyperkalemia/anemia therapy selection (iron/ESAs).
  • CKD-MBD treatment pros/cons (phos/Ca/vit D/PTH).
2024-08-29 Pharmacotherapy for Migraine Headaches including Botox for headaches and TMJ Dr. Christopher M. Bland Pharm.D., FCCP, FIDSA, BCPS 1 $25
  • Review older migraine strategies and when they fit.
  • Role of newer agents including botulinum toxin.
  • Apply best practices via cases.
2024-08-29 Pharmacotherapy of Alzheimers and Depression treatment and Adult Onset ADHD_ADD Dr. Joshua Caballero, Pharm.D., BCPP, FCCP 2 $50
  • Cognitive disorder treatments + comorbid psych management.
  • Counseling for patients/caregivers on expectations/options.
  • Adult ADHD: stimulant vs non-stimulant considerations.
2024-02-27 Pharmacology of GI Conditions Dr. Peter S. Buch, MD, AGAF, FACP 15 $225
  • IBS: patterns, alarm symptoms, therapy selection.
  • Elevated LFTs: NAFLD/NASH, biliary dilemmas, Hep C essentials.
  • Celiac vs non-celiac gluten sensitivity vs IBS workup.
  • GERD/dyspepsia/dysphagia; long-term PPI risks/benefits.
2024-01-09 DEA MATE Training Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA 15 $225
  • Opioid prescribing regs/guidelines + case studies.
  • Avoiding drug injury in older adults; high-risk controlled substances.
  • Addiction/SUD care: neurobiology, harm reduction, SBIRT.
  • Evidence-based SUD treatment: engagement, pharmacotherapy basics, ASAM criteria.

Accreditation Information

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).  This credit is applicable to health professionals who may require pharmacology credit.

NURSE PRACTITIONERS: This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours  for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

American Academy of Nurse Practitioners (AANP) accepts on demand courses approved for AMA PRA Category 1 Credit™. This program offers Category 2 credit only.

NURSES: University Learning Systems is Approved by the California Board of Registered Nursing, Provider Number CEP 11409, CE Broker: Arkansas, District of Columbia, Florida, Georgia, Kentucky, New Mexico, and West Virginia, Boards of Nursing.

PHYSICIANS: This CME program offers Category 2 credit.

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive MAINPRO-M2 credits for participation in this activity.

PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.